About this trial

The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care.

The main questions it aims to answer are:

1. Does targeting a higher urine sodium goal achieve greater natriuresis and diuresis? 2. Does targeting a higher urine sodium goal reduce frequency of hospital readmissions? 3. Does targeting a higher urine sodium goal reduce hospital length of stay?

Researchers will compare natriuresis-guided arms with standard of care to see if targeting higher natriuresis goals improves significantly over current practice.

Participants will submit urine samples at routine intervals after being given diuretics to evaluate urine sodium concentration. If urine sodium is low then diuretic dose will be increased.

Eligibility criteria

Qualifiers

Have a primary diagnosis of acute decompensated heart failure, and

Bilateral lower extremity pitting edema

Jugular venous distension

Hepatojugular reflex

Disqualifiers

Admission to the intensive care unit

Presence of ST-elevated myocardial infarction

Presence of type 1 non-ST elevated myocardial infarction

Dyspnea primarily due to non-cardiac cause as judged by the emergency medicine physician or admitting physician

Trial design

Treatments tested in this trial

  • Furosemide intravenous solution
  • Furosemide intravenous solution
  • Furosemide intravenous solution

Treatment groups

600 Participants
are divided into 3 treatment groups

Locations

1
Lakeland Regional Hospital33805, LakelandFlorida, United States

Sponsors and collaborators

Lakeland Regional Health Systems, Inc.

Lead sponsor